IL10 and colitis: In the TNBS-induced colitis group, the anti-inflammatory cytokine IL-10 levels in colonic tissue were significantly suppressed (p < 0.01 or p < 0.001) (Figure 3b), suggesting that both AL0035 and mesalazine treatments revealed to slow down this process.